Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Cochrane database of systematic reviews, August 2010
Williams K, Wheeler DM, Silove N, Hazell P, Williams, Katrina, Wheeler, Danielle M, Silove, Natalie, Hazell, Philip
Autism spectrum disorders (ASD) are characterised by abnormalities in social interaction and communication skills, as well as stereotypic behaviours and restricted activities and interests. Selective serotonin reuptake inhibitors (SSRIs) are prescribed for the treatment of co-morbidity associated with ASD such as depression, anxiety and obsessive-compulsive behaviours.
|Readers by professional status||Count||As %|
|Student > Master||10||13%|
|Student > Doctoral Student||10||13%|
|Student > Bachelor||9||12%|
|Student > Ph. D. Student||8||10%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||27||35%|
|Agricultural and Biological Sciences||8||10%|
|Nursing and Health Professions||5||6%|